Responses
Diabetes and endocrinology
Protocol
Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol
Compose a Response to This Article
Other responses
No responses have been published for this article.